Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
Al in Pathology Market by Neural Network (GAN, CNN, RNN), Function (Diagnostic, Image Analysis, CDSS, Data Management, Analytics), Use Case (Drug Discovery, Clinical workflow), End User (Hospital, Labs, Pharma/Biotech), & Region - Global Forecast to 2029
... 2029 The global AI in Pathology market is expected to reach USD 169.8 million by 2029 from USD 82.8 million in 2024 at a high CAGR of 15.4% during the forecast period. AI in pathology ... Read More
-
Small Molecule Drug Discovery Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Area (Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas), Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Geography
... and Other Therapeutic Areas), Process/Phase (Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development), and Geography The Small Molecule Drug Discovery market is anticipated to grow from US$ 50.93 billion in 2023 and ... Read More
-
Endocrinology Drugs Market by Therapy Area (Adrenal Insufficiency, Diabetes, Growth Hormone Disorders, Other Therapy Areas), Drug Class, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global endocrinology drugs market size was valued at $98.31 billion in 2024 and is projected to reach $145.89 billion by 2030, growing at a CAGR of 6.8% during the forecast period. Endocrinology Drugs Market ... Read More
-
Dermatology Drugs Market by Type (Cosmetic Dermatology, Cutaneous Lymphoma, Other Types), Route of Administration, Indication, Distribution Channel, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... The global dermatology drugs market size was valued at $33.39 billion in 2024 and is projected to reach $62.45 billion by 2030, growing at a CAGR of 11.0% during the forecast period. Dermatology Drugs Market ... Read More
-
Pemphigus Vulgaris (PV) - Market Insight, Epidemiology And Market Forecast - 2034
... ~15 million cases were diagnosed, and this number is projected to increase by the end of 2034 in the 7MM. In 2023, the market size of metabolic dysfunction-associated steatohepatitis (MASH) was highest in the US ... Read More
-
Global Musculoskeletal System Disorder Market Research Report 2024
... of 4.19% during the forecast period 2024-2030. North American market for Musculoskeletal System Disorder is estimated to increase from $ 77023 million in 2023 to reach $ 100034 million by 2030, at a CAGR of ... Read More
-
Pre-Eclampsia - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Pre-Eclampsia: Understanding ... Read More
-
Schizophrenia - Pipeline Insight, 2024
... stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Schizophrenia: Understanding Schizophrenia: ... Read More
-
Biopreservation Market Report Global Forecast By Product (Equipment, Media, Laboratory Information Management System (LIMS)), Application (Regenerative Medicine, Biobanking, Drug Discovery), Countries and Company Analysis (2025-2033)
... US$ 5.44 billion in 2024 and to reach US$ 24.51 billion by 2033, with a CAGR of 18.20% during 2025-2033. The main driving factors behind this growth include the rising demand for personalized medicine, R&D ... Read More
-
Type 2 Diabetes - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Cutaneous T-cell lymphoma - Pipeline Insight, 2024
... drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography ... Read More
-
Lou Gehrig’s disease - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Myotonic Dystrophy - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Alpha-1 Antitrypsin Deficiency Market Insight, Epidemiology and Market Forecast – 2034
... the United States accounted for 48% of the cases, while EU4 and the UK accounted for nearly 38% and Japan represented 14% of the cases, respectively. The idiopathic inflammatory myositis market is poised for rapid ... Read More
-
Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More
-
Degenerative Disc Disease Treatment Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... market size was valued at USD 26.05 billion in 2021, and the market is now projected to grow from USD 27.87 billion in 2022 to USD 45.92 billion by 2029, exhibiting a CAGR of 7.4% ... Read More
-
Smoking Cessation- Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Smoking ... Read More
-
Lupus Nephritis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Protein Therapeutics Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global protein therapeutics market by segmenting the market based on ... Read More
-
Myasthenia Gravis Treatment Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War
... 7.0% during 2025-2034. This report on global myasthenia gravis treatment market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of ... Read More
-
Biosimulation Market by Offering (Module, Integrated Platform), Application (Disease Modeling, PBPK, PKPD, Trial Simulation, Manufacturing & Supply chain: planning & forecasting), Indication (Cancer, CNS, CVS), End User, & Region - Global Forecast to 2029
... biosimulation market is projected to reach USD 9.18 billion by 2029 from USD 4.24 billion in 2024, at a CAGR of 16.7% from 2024 to 2029. Increasing need for cost and time reduction in the ... Read More
-
Metabolic Dysfunction-Associated Steatohepatitis (MASH) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatohepatitis (MASH). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) - Global Clinical Trials Review, 2024
... Steatotic Liver Disease (MASLD) Clinical trials scenario. This report provides top line data relating to the clinical trials on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Report includes an overview of trial numbers and their average ... Read More
-
Global Glioblastoma Multiforme Treatment Market 2024-2028
... period. The report on the glioblastoma multiforme treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Allergy Immunotherapies Market: Global Market Size, Forecast, Insights, and Competitive Landscape
... report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global allergy immunotherapies market by segmenting the market based on ... Read More
Research Assistance
